MacroGenics, Inc. (MGNX) — Analysis Summary
MacroGenics, Inc. (MGNX) has a market cap of $264.42M with year-over-year revenue growth of -0.3%. Net margin stands at -49.9%. The stock trades at a P/E ratio of -3.8.
Key Takeaways
- Revenue changed -0.3% year-over-year
- Net margin of -49.9%
- P/E ratio of -3.8
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, MGNX posted revenue growth of -0.3% and trades at a P/E of -3.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.